Mental Health Clinician最新文献_第8页

A retrospective analysis of inpatient utilization of paliperidone palmitate and readmission rates 回顾性分析住院患者使用棕榈酸帕利哌酮及再入院率

Mental Health Clinician Pub Date : 2014-12-23 DOI: 10.9740/MHC.N222763

M. Klug, April N. Smith, P. Price

引用次数: 0

What's new? Isomers, metabolites and prodrugs, oh my! 有什么新鲜事吗?同分异构体，代谢物和前药，天哪!

Mental Health Clinician Pub Date : 2014-12-23 DOI: 10.9740/MHC.N186960

A. Vandenberg

{"title":"What's new? Isomers, metabolites and prodrugs, oh my!","authors":"A. Vandenberg","doi":"10.9740/MHC.N186960","DOIUrl":"https://doi.org/10.9740/MHC.N186960","url":null,"abstract":"The terms racemic mixtures, single isomers, prodrugs, active metabolites, extended-release mechanisms were once remembered as the topics of early pharmacy school curriculum. Now they are often the source of confusion for practitioners and, sometimes, big money for manufacturers. Since 2011, nearly ten percent of the top 100 medications by sales were “new and improved” versions of previously released products with 4-5% being revised psychotropics. Since these “new” products are released as brand name agents under patent protection, they are often priced much higher than their predecessors. Clinical evidence is limited to approval trials – a handful of placebo-controlled and/or active-controlled efficacy studies. Rarely, if ever, are the new agents compared head-to-head with predecessor products. Clinicians are faced with marketing claims that, while true statements (e.g., “The starting dose is the proven effective dose”), may not have data to support clinical impact (i.e., differences in response or remission rates). In a time of financial strain for the healthcare system as a whole, the high cost of these new agents can be a hard pill to swallow. Evaluation of clinical utility must include efficacy, safety and cost as with any new medication. As head-to-head trials are extremely rare with these “new” medications, evidence-based comparisons may be limited to pharmacokinetic and pharmacodynamic properties of products. It is also important to use clinical common sense to compare new agents to their predecessors.","PeriodicalId":18691,"journal":{"name":"Mental Health Clinician","volume":"23 1","pages":"1-1"},"PeriodicalIF":0.0,"publicationDate":"2014-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87618651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Treatment-resistant depression 难治性抑郁症

Mental Health Clinician Pub Date : 2014-12-23 DOI: 10.9740/MHC.N207177

Amy Werremeyer

引用次数: 1

Impact of nighttime donepezil administration on sleep in the older adult population: A retrospective study 夜间服用多奈哌齐对老年人睡眠的影响:一项回顾性研究

Mental Health Clinician Pub Date : 2014-12-23 DOI: 10.9740/MHC.N222761

C. Agboton, Soheyla Mahdavian, Angela Singh, P. Ghazvini, Angela M. Hill, R. Sweet

引用次数: 9

Emerging therapies for treatment resistant depression 治疗难治性抑郁症的新疗法

Mental Health Clinician Pub Date : 2014-12-23 DOI: 10.9740/MHC.N207179

R. Wijesinghe